PropertyValue
?:abstract
  • From the Document: \'This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the VIDAS® [Vitek Immuno Diagnostic Assay System] SARS-COV-2 [severe acute respiratory syndrome coronavirus 2] IgG [immunoglobulin G] [ ] This test detects human SARS-CoV-2 antibodies that are generated as part of the human adaptive immune response to the COVID-19 [coronavirus disease 2019] virus and is to be performed on only serum or plasma (lithium heparin) specimens \'
?:creator
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Fact Sheet for Healthcare Providers: bioMerieux, Inc.;VIDAS® SARS-COV-2 IgG
?:type
?:who_covidence_id
  • #740221
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/nndp0rhd>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/nndp0rhd>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all